Gpdt photodynamic micro-lipo encapsulation

TWM688837UActive Publication Date: 2026-10-21陳耀寬 +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115205887
Authority / Receiving Office
TW · TW
Patent Type
Utility models
Current Assignee / Owner
Filing Date
2026-06-25
Publication Date
2026-10-21
Estimated Expiration
2036-06-24

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

This invention discloses a micro-liposome structure for a GPDT photodynamic therapy formulation, comprising an outer layer and a core. The outer layer includes a lipid bilayer membrane; the core is coated by the outer layer and includes a GPDT photodynamic therapy formulation. This allows for the formation of a micro-liposome structure to serve as a carrier for the GPDT photodynamic therapy formulation, improving coating effectiveness, stability, and absorption and utilization.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A micro-liposome structure of a GPDT photodynamic formulation, comprising: an outer layer including a lipid bilayer membrane; and a spherical core covered by the outer layer and including a GPDT photodynamic formulation.

2. The liposome structure of the GPDT photodynamic formulation as described in claim 1, wherein, This lipid bilayer membrane is formed by the arrangement of multiple phospholipid molecules.

3. The liposome structure of the GPDT photodynamic formulation as described in claim 1, wherein, This GPDT photodynamic therapy formulation contains chlorophyll derivatives, alkaloids, sitosterol, isoprene flavonoids, and artemisinin C.

4. The liposome structure of the GPDT photodynamic formulation as described in claim 3, wherein, This chlorophyll derivative is derived from wheatgrass extract and mulberry leaf extract.

5. The liposome structure of the GPDT photodynamic formulation as described in claim 3, wherein, The alkaloids and sitosterols are derived from mulberry leaf extract, while the isoprene flavonoids and artemisinin C are derived from propolis extract.

6. The liposome structure of the GPDT photodynamic formulation as described in claim 3, wherein, The GPDT photodynamic therapy also contains catechins, epigallocatechin gallate, sulforaphane, glucosinolates, curcumin, Ganoderma lucidum polysaccharides, and fucoidan.

7. The GPDT photodynamic formulation liposome structure as described in claim 6, wherein, The catechins and epigallocatechin gallate are derived from green tea extract, the sulforaphane is derived from broccoli extract, the glucosinolate is derived from kale extract, the curcumin is derived from green turmeric extract, the Ganoderma lucidum polysaccharide is derived from black Ganoderma lucidum extract, and the fucoidan is derived from brown algae extract.